Worth Watching Stocks: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Duke Realty Corporation (NYSE:DRE), Dorchester Minerals LP (NASDAQ:DMLP), Syneron Medical Ltd. (NASDAQ:ELOS)

TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) announced financial results for the second quarter ended June 30, 2015. Cash, cash equivalents, and marketable securities totaled $34.8 million at June 30, 2015, as compared to $53.7 million at December 31, 2014.TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) shares advanced 2.40% in last trading session and ended the day at $2.56. TLOG return on assets is -36.30%. TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) quarterly performance is -1.92%.

Zacks upgraded shares of Duke Realty Corporation (NYSE:DRE) from a hold rating to a buy rating in a research report released on Tuesday morning. The brokerage currently has $23.00price target on the real estate investment trust’s stock. On 06 August, Duke Realty Corporation (NYSE:DRE) shares moved down -0.05% and was closed at $19.82. DRE EPS growth in last 5 year was 18.70%. Duke Realty Corporation (NYSE:DRE) year to date (YTD) performance is -0.22%.

Dorchester Minerals LP (NASDAQ:DMLP) announced the Partnership’s net income for the quarter ended June 30, 2015 of $3,816,000 or $0.12 per common unit. The Partnership previously declared its second quarter distribution in the amount of $0.167430 per common unit paid on August 6, 2015 to common unit holders of record as of July 27, 2015. Dorchester Minerals LP (NASDAQ:DMLP) ended the last trading day at $14.85. Company weekly volatility is calculated as 6.96% and price to cash ratio as 42.57. Dorchester Minerals LP (NASDAQ:DMLP) showed a weekly performance of -14.41%.

On 4 August, Syneron Medical Ltd. (NASDAQ:ELOS) reported Q2 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $73.5 million versus the consensus estimate of $70.93 million. Syneron Medical Ltd. (NASDAQ:ELOS) shares moved down -3.25% in last trading session and ended the day at $9.82. ELOS Gross Margin is 53.10% and its return on assets is -1.80%. Syneron Medical Ltd. (NASDAQ:ELOS) quarterly performance is -21.12%.

Leave a Reply

Your email address will not be published. Required fields are marked *